Top Links

Articles Related to Prostate cancer

Image-Guided Radiotherapy Using MV for Prostate Cancer: A Correlation Analysis between Electronic Portal Imaging with Fiducial Markers and Cone Beam CT

IGRT combined with three-dimensional conformal radiation therapy (3D CRT) and intensity-modulated radiation therapy (IMRT) is gaining quick acceptance in radiotherapy treatment of prostate cancer [1-4]. The advantage of this technique is that it localizes the target volume accurately, thus increasing precision in treatment delivery.
View complete article: PDF  |  Full-text

Development of Severe Hypophosphatemia from Acquired Fanconi Syndrome during Treatment with Abiraterone

The first patient was a 77 year old man who had been on abiraterone for 12 months before his phosphorous was checked. At that point, it was 0.6 mg/dl, which is severely decreased. A full work up for hypophosphatemia showed normal parathyroid hormone and 25-hydroxyvitamin D. A urine study showed inappropriate excretion of phosphorous along with aminoaciduria and normoglycemic glucosuria.
View complete article: PDF  |  Full-text

Targeted Approach for Prostate Cancer Treatment: Synthesis and Characterization of Docetaxel-Loaded Perfluorocarbon Nanodroplets

The purpose of this study is to synthesize and characterize nanodroplets, loaded with docetaxel for treatment of prostate cancer under MR-guided focused ultrasound. Water insoluble docetaxel encapsulated in nanodroplets is expected to be delivered into tumors with greater efficiency while minimizing drug related systemic toxicities when used in combination with focused ultrasound. The sequence of our studies toward development and characterization of docetaxel-loaded nanodroplets is as follows. First, we developed methods for synthesis of ultrasound-responsive, docetaxel-loaded nanodroplets (Doc-nd) by a solid dispersion technique. Secondly, we characterized Doc-nd by its morphology and size distributions using a dynamic light scattering (DLS) method.
View complete article: PDF  |  Full-text

Prostate Cancer – Double Vision but Solitary Lesion

A 53 year old man with a background of castrate-sensitive prostate cancer on intermittent androgen deprivation therapy (ADT) presented with right sixth nerve palsy secondary to a solitary right petroclival lesion involving adjacent dura and bone. The clinical and imaging characteristics of the lesion were consistent with a number of differential diagnoses (including metastatic prostate cancer, meningioma and chondrosarcoma).
View complete article: PDF  |  Full-text


Editorial Board Members Related to Prostate cancer

Subash Sad

Professor
Department of Biochemistry, Microbiology and Immunology
University of Ottawa
Canada

Lucia Gutierrez Bayard

Associate Professor
Department of Radiation Oncology
Hospital Universitario Puerta del Mar
Spain

ALI AMIN

Assistant Professor
Warren Alpert Medical School
Brown University
United States

Mridula Chopra

Senior Lecturer
School of Pharmacy and Biomedical Sciences
University of Portsmouth
United Kingdom

VEENA N. RAO

Professor
Department of Obstetrics and Gynecology
Morehouse School of Medicine
Georgia Cancer Center for excellence
United States

Ock K. Chun

Assistant Professor
Department of Nutritional Sciences
University of Connecticut
United States

Jianfei Qi

Assistant Professor
Biochemistry and Molecular Biology
University of Maryland School of Medicine
United States

Ray Kirk

Associate Professor
School of Health Sciences
University of Canterbury
New Zealand
Submit Manuscript